Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): BR112020016331-7 [WO2019160751]
Who filed: ABIA (Associação Brasileira Interdisciplinar de AIDS)
Country: Brazil
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 23-05-2025
Patent type: Indication

Click within the document, or manually enter the page number below

ABIA opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2015
ABIA opposition, TAF, (PI0112646-6)

Countries: Brazil Date: 2016
ABIA/GTPI opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2020
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6 - WO200208241)

Countries: Brazil Date: 2016
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir disoproxil fumarate/Emtricitabine, (PI0406760-6 - WO2004064845)

Countries: Brazil Date: 2016
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Dolutegravir, (PI0610030-9 (US 2006/016604 - WO 2006/116764))

Countries: Brazil Date: 2019
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6)

Countries: Brazil Date: 2018
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2019

Abia (Associação Brasileira Interdisciplinar De Aids) Opposition, Pembrolizumab [Keytruda], (Br112020016331 7 [Wo2019160751])